Post-COVID paediatric dysautonomia is best conceptualised as a distributed brain-heart-vascular network disorder rather than a primary cardiac abnormality
The paper argues that post-COVID dysautonomia in children arises from complex interactions among central autonomic network dysfunction, neurovascular dysregulation, and impaired venous return, with tachycardia representing a compensatory physiological response. Clinical phenotypes include POTS, neurocardiogenic syncope, and orthostatic intolerance, often accompanied by fatigue, cognitive dysfunction, and sleep disturbances.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Post-COVID paediatric dysautonomia is best conceptualised as a distributed brain-heart-vascular network disorder rather than a primary cardiac abnormality The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Post-COVID paediatric dysautonomia is best conceptualised as a distributed brain-heart-vascular network disorder rather than a primary cardiac abnormality
This conclusion is most relevant to: Children and adolescents with post-COVID dysautonomia.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim? (Cardiology in the young, 2026) —
How It Works
The proposed biological pathway:
- ▸Central autonomic network dysfunction
- ▸Neurovascular dysregulation and impaired venous return
- ▸Endothelial injury and hypovolemia
- ▸Altered cerebral perfusion leading to compensatory tachycardia
Who Might Benefit
Evidence fit by population:
- ▸Children and adolescents with post-COVID dysautonomia
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Reported prevalence varies widely due to evolving definitions and heterogeneous referral patterns
- ▸Important gaps remain in disease definitions, mechanistic understanding, and evidence-based treatment
Frequently Asked Questions
What is post-COVID paediatric dysautonomia?▼
It is a condition in children and adolescents following COVID-19, involving dysfunction of the autonomic nervous system, presenting with symptoms like dizziness, palpitations, fatigue, and syncope.
Is post-COVID dysautonomia primarily a heart problem?▼
No, the paper argues it is primarily a brain-heart-vascular network disorder, with tachycardia being a compensatory response rather than a primary cardiac abnormality.
What are the common clinical phenotypes?▼
Common phenotypes include postural orthostatic tachycardia syndrome (POTS), neurocardiogenic syncope, orthostatic hypotension, inappropriate sinus tachycardia, and undifferentiated orthostatic intolerance.
How is post-COVID dysautonomia managed?▼
Management follows a stepwise approach including patient education, trigger avoidance, hydration and salt optimisation, lower-body compression, exercise rehabilitation, pacing strategies, school accommodations, and phenotype-directed pharmacotherapy.
References
- 1.Das B, Moodley M. “Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim?.” Cardiology in the young, 2026. PMID: 42403377 DOI: 10.1017/S1047951126113900